Stock listing

NASDAQ:BIVV Bioverativ Inc Stock

Follow Bioverativ Inc into a list and get an email when it puts out news.

Last close · NASDAQ:BIVV

$104.98 USD

Close on Mar 8, 2018 · No longer trades

Feb 2, 2017 to last close +133.4% · daily closes, Feb 2, 2017 – Mar 8, 2018
Lowest – highest close
$42.40 – $104.98 USDSince Feb 2, 2017 · lowest Feb 9, 2017 · highest Mar 8, 2018

Delisted NASDAQ:BIVV no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:BIVV
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Bioverativ Inc on 6ix

Decks
1 deck · latest Jan 6, 2017

Decks

DeckKindSlidesDate
Investor Day (January 2017)Investor day50 slidesJan 6, 2017

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Geno Germano
Other companies: Harmony Biosciences Holdings, Inc. (Director · Since at least Apr 2, 2026); Entera Bio Ltd. (Chairman of the Board · Since at least Feb 4, 2026); Precision BioSciences, Inc. (Director · Since at least Mar 10, 2020); Sage Therapeutics Inc (Director · Since at least Jun 6, 2018); The Medicines Company (Director · Nov 9, 2017 – Jan 6, 2020 · Past)
Director · Jan 31, 2018 – Mar 8, 2018 · Past
Anna Protopapas
Other companies: Nuvalent, Inc. (Director · Since at least Mar 30, 2022); Mersana Therapeutics Inc (Director · Since at least Jun 27, 2017); Dicerna Pharmaceuticals Inc (Director · Jan 23, 2019 – Jun 3, 2021 · Past); Ariad Pharmaceuticals Inc (Director · Feb 1, 2016 – Feb 16, 2017 · Past)
Director · Feb 28, 2017 – Mar 8, 2018 · Past
John Cox
Other companies: Dyne Therapeutics, Inc. (President and Chief Executive Officer · Since at least Mar 25, 2024); Sigilon Therapeutics Inc (Director · Dec 3, 2020 – Aug 11, 2023 · Past); Repligen Corporation (Director · Nov 15, 2013 – Mar 24, 2020 · Past); Biogen Inc. (EVP Pharmaceutical Oper & Tech · Nov 1, 2011 – Apr 1, 2016 · Past)
Chief Executive Officer, Director · Dec 22, 2016 – Mar 8, 2018 · Past
John Greene
Other companies: Northrop Grumman Corporation (Corporate Vice President and Chief Financial Officer · Since at least Jan 7, 2026); CRISPR Therapeutics AG (Director · Since at least Jun 11, 2019); Discover Financial Services (EVP, Chief Financial Officer · Sep 18, 2019 – May 18, 2025 · Past); Willis Towers Watson Public Limited Company (Chief Financial Officer · Jun 2, 2014 – Nov 9, 2015 · Past)
EVP, CFO and Treasurer · Dec 22, 2016 – Mar 8, 2018 · Past
Andrea DiFabio
Other companies: Xenon Pharmaceuticals Inc. (Chief Legal Officer and Corporate Secretary · Since at least Nov 7, 2022)
EVP, Chief Legal Officer · Dec 22, 2016 – Mar 8, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Bioverativ Inc.